261 related articles for article (PubMed ID: 31340741)
21. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids
Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M
Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
23. InCl3-catalysed synthesis of 2-aryl quinazolin-4(3H)-ones and 5-aryl pyrazolo[4,3-d]pyrimidin-7(6H)-ones and their evaluation as potential anticancer agents.
Mulakayala N; Kandagatla B; Ismail ; Rapolu RK; Rao P; Mulakayala C; Kumar CS; Iqbal J; Oruganti S
Bioorg Med Chem Lett; 2012 Aug; 22(15):5063-6. PubMed ID: 22749421
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety.
Zhang H; Xin MH; Xie XX; Mao S; Zuo SJ; Lu SM; Zhang SQ
Bioorg Med Chem; 2015 Dec; 23(24):7765-76. PubMed ID: 26652969
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4(3H)-ones.
Sabry MA; Ewida HA; Hassan GS; Ghaly MA; El-Subbagh HI
Bioorg Chem; 2019 Jul; 88():102923. PubMed ID: 30991189
[TBL] [Abstract][Full Text] [Related]
26. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
Hieu DT; Anh DT; Hai PT; Thuan NT; Huong LT; Park EJ; Young Ji A; Soon Kang J; Phuong Dung PT; Han SB; Nam NH
Chem Biodivers; 2019 Apr; 16(4):e1800502. PubMed ID: 30653817
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and
Le Y; Gan Y; Fu Y; Liu J; Li W; Zou X; Zhou Z; Wang Z; Ouyang G; Yan L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):555-564. PubMed ID: 31967481
[TBL] [Abstract][Full Text] [Related]
28. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity and Antibacterial Evaluation of O-Alkylated/Acylated Quinazolin-4-one Schiff Bases.
Manhas N; Singh P; Mocktar C; Singh M; Koorbanally N
Chem Biodivers; 2021 May; 18(5):e2100096. PubMed ID: 33724670
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.
Srinivas M; Singh Pathania A; Mahajan P; Verma PK; Chobe SS; Malik FA; Nargotra A; Vishwakarma RA; Sawant SD
Bioorg Med Chem Lett; 2018 Apr; 28(6):1005-1010. PubMed ID: 29486969
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of a novel series of 6,8-dibromo-4(3H)quinazolinone derivatives as anticancer agents.
Ahmed MF; Youns M
Arch Pharm (Weinheim); 2013 Aug; 346(8):610-7. PubMed ID: 23873839
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of 2-substituted Furo[3,2-b]pyridines Under Pd/C-Cu Catalysis Assisted by Ultrasound: Their Evaluation as Potential Cytotoxic Agents.
Laxmi DS; Vardhini SV; Guttikonda VR; Rao MVB; Pal M
Anticancer Agents Med Chem; 2020; 20(8):932-940. PubMed ID: 32160853
[TBL] [Abstract][Full Text] [Related]
33. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
34. 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.
Rizza P; Pellegrino M; Caruso A; Iacopetta D; Sinicropi MS; Rault S; Lancelot JC; El-Kashef H; Lesnard A; Rochais C; Dallemagne P; Saturnino C; Giordano F; Catalano S; Andò S
Eur J Med Chem; 2016 Jan; 107():275-87. PubMed ID: 26599533
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers.
Mahdy HA; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; El-Gamal KMA; El-Sharkawy A; Elhendawy MA; Radwan MM; Elsohly MA; Eissa IH
Bioorg Chem; 2020 Jan; 94():103422. PubMed ID: 31812261
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
Al-Rashood ST; Hassan GS; El-Messery SM; Nagi MN; Habib EE; Al-Omary FAM; El-Subbagh HI
Bioorg Med Chem Lett; 2014 Sep; 24(18):4557-4567. PubMed ID: 25139568
[TBL] [Abstract][Full Text] [Related]
37. Survey of recent literature related to the biologically active 4(3H)-quinazolinones containing fused heterocycles.
Demeunynck M; Baussanne I
Curr Med Chem; 2013 Feb; 20(6):794-814. PubMed ID: 23276134
[TBL] [Abstract][Full Text] [Related]
38. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines.
Lan TT; Anh DT; Pham-The H; Dung DTM; Park EJ; Jang SD; Kwon JH; Kang JS; Thuan NT; Han SB; Nam NH
Chem Biodivers; 2020 Jul; 17(7):e2000290. PubMed ID: 32356584
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives.
Khodair AI; Alsafi MA; Nafie MS
Carbohydr Res; 2019 Dec; 486():107832. PubMed ID: 31622868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]